STOCK TITAN

SOPHiA GENETICS to Participate in Fireside Chat at Barclays Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

SOPHiA GENETICS (Nasdaq: SOPH) has announced that CEO Dr. Jurgi Camblong will speak at the Barclays Global Healthcare Conference on March 16, 2022, at 11:15 a.m. ET. The event will be held at the Loews Miami Beach Hotel, Miami, FL. A live webcast of the session will be available on the investor relations section of the SOPHiA GENETICS website.

This healthcare technology company focuses on data-driven medicine, utilizing its SOPHiA DDM™ Platform to analyze complex data sets for over 790 global healthcare institutions.

Positive
  • None.
Negative
  • None.

BOSTON and LAUSANNE, Switzerland, March 04, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, announced today Chief Executive Officer and Co-Founder Dr. Jurgi Camblong will participate in a fireside chat at the Barclays Global Healthcare Conference on Wednesday, March 16 at 11:15 a.m. ET/5:15 p.m. CET at the Loews Miami Beach Hotel in Miami, FL, United States.

A live webcast and replay of the session will be available on the investor relations section of the SOPHiA GENETICS website at https://ir.sophiagenetics.com.

About SOPHiA GENETICS

SOPHiA GENETICS (Nasdaq: SOPH) is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by more than 790 hospital, laboratory, and biopharma institutions globally. For more information, visit SOPHiAGENETICS.COM, or connect on Twitter, LinkedIn and Instagram. Where others see data, we see answers.

Investor Contact:
Jennifer Pottage
Head of Investor Relations
Jpottage@sophiagenetics.com

Media Contact:
Eliza Bamonti
Director of Public Relations
Ebamonti@sophiagenetics.com


FAQ

When will SOPHiA GENETICS CEO Dr. Jurgi Camblong speak at the Barclays Global Healthcare Conference?

Dr. Jurgi Camblong will speak at the Barclays Global Healthcare Conference on March 16, 2022, at 11:15 a.m. ET.

Where is the Barclays Global Healthcare Conference being held?

The Barclays Global Healthcare Conference will take place at the Loews Miami Beach Hotel in Miami, FL, United States.

How can I watch the SOPHiA GENETICS session at the Barclays Conference?

You can watch the live webcast of the session on the investor relations section of the SOPHiA GENETICS website.

What is the main focus of SOPHiA GENETICS?

SOPHiA GENETICS is dedicated to establishing data-driven medicine as a standard of care and in life sciences research.

How many institutions use the SOPHiA DDM™ Platform?

The SOPHiA DDM™ Platform is currently used by more than 790 hospitals, laboratories, and biopharma institutions globally.

SOPHiA GENETICS SA Ordinary Shares

NASDAQ:SOPH

SOPH Rankings

SOPH Latest News

SOPH Stock Data

241.89M
65.38M
5.84%
49.85%
0.02%
Health Information Services
Healthcare
Link
United States of America
Rolle